Switch Therapeutics Raises $52M to Advance First-of-its-Kind RNAi Technology
Switch Therapeutics has announced its launch after raising $52 million in financing, with its Series A round being co-led by Insight Partners and UCB Ventures. Other investors that contributed to the round included existing investors Upfront Ventures and BOLD Capital Partners, as well as new investors Eli Lilly and Company, Ono Venture Investment, Digitalis Ventures, … Read more